Protosappanin A Alleviates Atherosclerosis by Regulating the MDM2 / GPX4 Axis‐Mediated Endothelial Ferroptosis
Phytotherapy Research · 2026-11 · 40 (11) · 6450-6467
DOI: 10.1002/ptr.70443 ↗At a glance
Journal article in Phytotherapy Research, published online on 2026-09-08. Written by Jiamei Fu and 6 co-authors. Institution: The First Hospital Affiliated to Heilongjiang University of Chinese Medicine, Harbin, China. Major MEDLINE topics: Ferroptosis, Atherosclerosis, Phospholipid Hydroperoxide Glutathione Peroxidase, Proto-Oncogene Proteins c-mdm2. 40 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Natural Science Foundation Cultivation Program of the First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Heilongjiang Provincial Postdoctoral Research Foundation, Young Scientific and Technological Innovation Capability Training Program under the Scientific Research Fund of Heilongjiang University of Chinese Medicine.
Abstract (original language)
Endothelial ferroptosis is a crucial pathogenic driver of atherosclerosis (AS) progression. Protosappanin A (PTA), a bioactive compound from Caesalpinia sappan L., protects cardiovascular vessels by regulating ferroptosis. However, whether PTA inhibits AS specifically through suppressing endothelial ferroptosis remains unclear. To address this, ApoE −/− mice were fed a high‐fat diet for 16 weeks to induce atherosclerosis, and PTA or simvastatin was administered daily from Week 4 through Week 16 (12 weeks of intervention). PTA markedly reduced aortic plaque area (en face Oil Red O and H&E staining) and improved serum lipid profiles (TG, TC, LDL‐C, HDL‐C). It also alleviated endothelial injury, evidenced by decreased VCAM‐1 and ICAM‐1 expression. Mechanistically, PTA ameliorated mitochondrial ferroptosis in endothelial cells, lowered intracellular Fe 2+ and lipid peroxidation (MDA, lipid ROS), and restored the expression of GPX4, xCT, and FTH1. Immunofluorescence confirmed that PTA upregulated GPX4 within the aortic endothelium. To explore the underlying mechanism, we performed RNA‐seq on ox‐LDL‐treated HUVECs and integrated the data with ferroptosis‐related databases. MDM2 was identified as a key target, which was validated by qPCR and Western blotting. Overexpression of MDM2 activated endothelial ferroptosis and reversed the protective effects of PTA both in vitro and in vivo. Collectively, these findings demonstrate that PTA alleviates AS by suppressing endothelial ferroptosis via the MDM2/GPX4 axis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- The First Hospital Affiliated to Heilongjiang University of Chinese Medicine, Harbin, China.
- Postdoctoral Research Station, Heilongjiang University of Chinese Medicine, Harbin, China.
- Heilongjiang University of Chinese Medicine, Harbin, China.
ORCID profiles: Jiamei Fu, Yabin Zhou
Funding
- National Natural Science Foundation Cultivation Program of the First Affiliated Hospital of Heilongjiang University of Chinese Medicine
- Heilongjiang Provincial Postdoctoral Research Foundation
- Young Scientific and Technological Innovation Capability Training Program under the Scientific Research Fund of Heilongjiang University of Chinese Medicine
- Heilongjiang Provincial Scientific Research Project on Traditional Chinese Medicine
Cite
APA
Fu, J., Zhu, L., Yang, W., Li, M., Wu, Z., Sun, S., & Zhou, Y. (2026). Protosappanin A Alleviates Atherosclerosis by Regulating the MDM2 / GPX4 Axis‐Mediated Endothelial Ferroptosis. Phytotherapy Research, 40(11), 6450-6467. https://doi.org/10.1002/ptr.70443
Vancouver
Fu J, Zhu L, Yang W, Li M, Wu Z, Sun S, et al. Protosappanin A Alleviates Atherosclerosis by Regulating the MDM2 / GPX4 Axis‐Mediated Endothelial Ferroptosis. Phytotherapy Research. 2026;40(11):6450-6467. doi:10.1002/ptr.70443
BibTeX
@article{Fu2026,
author = {Fu, Jiamei and Zhu, Lin and Yang, Wenwei and Li, Mengnan and Wu, Zhixin and Sun, Shude and Zhou, Yabin},
title = {Protosappanin A Alleviates Atherosclerosis by Regulating the MDM2 / GPX4 Axis‐Mediated Endothelial Ferroptosis},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {11},
pages = {6450--6467},
doi = {10.1002/ptr.70443}
}
EUVIMED